Sinovac Biotech (SVA) Ending Cash Balance (2009 - 2026)
Sinovac Biotech (SVA) recorded Ending Cash Balance of $998.55 million in Q2 2026, down 76.0% from $4.16 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Sinovac Biotech reported Ending Cash Balance of $1.16 billion, up 92.0% from FY2024.
- Annual Ending Cash Balance has a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- Across earlier years, Ending Cash Balance came in at $602.22 million in FY2024 (-46.7%), $1.13 billion in FY2023 (-71.0%), $3.89 billion in FY2022 (-66.5%) and $11.62 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly Ending Cash Balance since Q4 2024.
- On a year-over-year basis, Ending Cash Balance rose in two of the last four quarters, with growth averaging 75.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 998.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 998.55 Mn |
| Dec 31, 2025 | 4.16 Bn |
| Jun 30, 2025 | 4.16 Bn |
| Dec 31, 2024 | 602.22 Mn |
| Jun 30, 2024 | 959.12 Mn |
| Dec 31, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.65 Bn |
| Dec 31, 2022 | 3.89 Bn |
| Jun 30, 2022 | -8.34 Bn |
| Dec 31, 2021 | 11.62 Bn |
| Jun 30, 2021 | 6.86 Bn |
| Dec 31, 2020 | 1.05 Bn |
| Sep 30, 2020 | 153.71 Mn |
| Jun 30, 2020 | 155.88 Mn |
| Mar 31, 2020 | 168.46 Mn |
| Dec 31, 2019 | 155.88 Mn |
| Sep 30, 2019 | 156.70 Mn |
| Jun 30, 2019 | 151.69 Mn |
| Mar 31, 2019 | 149.05 Mn |
| Dec 31, 2018 | 158.17 Mn |
API Access
Sinovac Biotech Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();